Search Results - "Head and Neck Neoplasms/mortality"

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Authors: Uppaluri, Ravindra Haddad, Robert I Tao, Yungan et al.

Source: New England Journal of Medicine. 393:37-50

Subject Terms: Adult, Male, Antibodies, Monoclonal, Humanized / adverse effects, Antibodies, Monoclonal, Humanized / administration & dosage, Young Adult, Chemotherapy, Adjuvant / methods, B7-H1 Antigen / analysis, B7-H1 Antigen / antagonists & inhibitors, Humans, Neoadjuvant Therapy / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Antineoplastic Agents, Immunological / adverse effects, Aged, Aged, 80 and over, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / pathology, Squamous Cell Carcinoma of Head and Neck / pathology, Middle Aged, Head and Neck Neoplasms / drug therapy, Neoadjuvant Therapy / methods, Progression-Free Survival, Squamous Cell Carcinoma of Head and Neck / surgery, Intention to Treat Analysis, B7-H1 Antigen / metabolism, Treatment Outcome, Head and Neck Neoplasms / surgery, Squamous Cell Carcinoma of Head and Neck / drug therapy, Female, Chemotherapy, Adjuvant / adverse effects, Squamous Cell Carcinoma of Head and Neck / mortality

File Description: application/pdf

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 'OMET' Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

Authors: Juliette Thariat Mathieu Bosset Antoine Falcoz et al.

Contributors: Juliette Thariat Mathieu Bosset Antoine Falcoz et al.

Source: International journal of radiation oncology, biology, physics, vol. 121, no. 5, pp. 1194-1206

Subject Terms: Humans, Quality of Life, Radiosurgery/methods, Radiosurgery/mortality, Male, Female, Middle Aged, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/pathology, Head and Neck Neoplasms/therapy, Head and Neck Neoplasms/radiotherapy, Head and Neck Neoplasms/drug therapy, Aged, Neoplasm Metastasis, Cetuximab/administration & dosage, Cetuximab/therapeutic use, Fluorouracil/administration & dosage, Squamous Cell Carcinoma of Head and Neck/mortality, Squamous Cell Carcinoma of Head and Neck/therapy, Squamous Cell Carcinoma of Head and Neck/secondary, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Adult, Survival Rate

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39612953
https://serval.unil.ch/resource/serval:BIB_F3A45574859E.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F3A45574859E1
https://serval.unil.ch/notice/serval:BIB_F3A45574859E

Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes—a single centre analysis

Authors: Schleifenbaum, Julia Katharina Morgenthaler, Janis Sharma, Shachi Jenny et al.

Source: Radiat Oncol
Radiation Oncology, Vol 20, Iss 1, Pp 1-12 (2025)

Subject Terms: Male, Adult, PEG tube, R895-920, Salvage therapy, Re-Irradiation, Medical physics. Medical radiology. Nuclear medicine, Biomarkers, Gastrostomy [MeSH], Squamous Cell Carcinoma of Head and Neck/radiotherapy [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Squamous Cell Carcinoma of Head and Neck/pathology [MeSH], Re-Irradiation [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Reirradiation, Male [MeSH], Squamous Cell Carcinoma of Head and Neck/mortality [MeSH], Biomarkers, Tumor [MeSH], Female [MeSH], Recurrent head and neck cancer, Adult [MeSH], Humans [MeSH], Inflammation, Salvage Therapy [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Head and Neck Neoplasms/mortality [MeSH], Survival Rate [MeSH], Head and Neck Neoplasms/radiotherapy [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Research, Prognosis [MeSH], Radiotherapy Dosage [MeSH], Head and Neck Neoplasms/pathology [MeSH], Biomarkers, Tumor, Humans, RC254-282, Aged, Retrospective Studies, Salvage Therapy, Gastrostomy, Aged, 80 and over, Squamous Cell Carcinoma of Head and Neck, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Radiotherapy Dosage, Middle Aged, Prognosis, Survival Rate, Head and Neck Neoplasms, Female, Neoplasm Recurrence, Local

Access URL: https://pubmed.ncbi.nlm.nih.gov/39748422
https://doaj.org/article/df5b2f289c26432188c384079ee85474
https://repository.publisso.de/resource/frl:6491048

Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience

Authors: Ahmed Allam Mohamed Miguel Goncalves Biney Pal Singh et al.

Source: Strahlenther Onkol
Strahlentherapie und Onkologie 200(5), 400-408 (2023). doi:10.1007/s00066-023-02180-9

Subject Terms: Male, Adult, Aged, 80 and over, Middle Aged, Radiosurgery, Prognosis, Progression-Free Survival, 3. Good health, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Humans, Original Article, Female, Neoplasm Recurrence, Local, Neoplasm Metastasis, 10. No inequality, Carcinoma, Squamous Cell/mortality [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Progression-Free Survival [MeSH], SABR, Male [MeSH], Carcinoma, Squamous Cell/surgery [MeSH], Carcinoma, Squamous Cell/secondary [MeSH], Carcinoma, Squamous Cell/pathology [MeSH], Carcinoma, Squamous Cell/radiotherapy [MeSH], Neoplasm Metastasis/radiotherapy [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Head and Neck Neoplasms/mortality [MeSH], Radiosurgery [MeSH], Head and Neck Neoplasms/radiotherapy [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Prognosis [MeSH], Neoplasm metastasis, Metastasis directed therapy, Oligometastasis, Head and Neck Neoplasms/pathology [MeSH], Aged

Access URL: https://pubmed.ncbi.nlm.nih.gov/38063900
https://repository.publisso.de/resource/frl:6520031
https://publications.rwth-aachen.de/record/975102

Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma

Authors: Fu, Ling-ling Yan, Ming Yu, Xin et al.

Source: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)

Subject Terms: Male, RBP1, Squamous Cell Carcinoma of Head and Neck, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Head and neck squamous cell carcinoma, Retinol-Binding Proteins, Cellular, Prognosis biomarker, DNA Methylation, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, Nomograms, Gene Expression Regulation, Neoplastic [MeSH], Aged [MeSH], Squamous Cell Carcinoma of Head and Neck/pathology [MeSH], Retinol-Binding Proteins, Cellular [MeSH], Head and Neck Neoplasms/genetics [MeSH], RNA, Messenger/genetics [MeSH], Male [MeSH], Squamous Cell Carcinoma of Head and Neck/mortality [MeSH], Retinol-Binding Proteins, Plasma/genetics [MeSH], RNA, Messenger/metabolism [MeSH], Female [MeSH], Squamous Cell Carcinoma of Head and Neck/metabolism [MeSH], Bioinformatic analysis, Humans [MeSH], Head and Neck Neoplasms/metabolism [MeSH], Retinol-Binding Proteins, Plasma/metabolism [MeSH], Middle Aged [MeSH], Head and Neck Neoplasms/mortality [MeSH], Squamous Cell Carcinoma of Head and Neck/genetics [MeSH], Nomograms [MeSH], Biomarkers, Tumor/metabolism [MeSH], DNA Methylation [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Head and Neck Neoplasms/pathology [MeSH], Head and Neck Neoplasms, Biomarkers, Tumor, Humans, Female, RNA, Messenger, Retinol-Binding Proteins, Plasma, RC254-282, Aged

Access URL: https://pubmed.ncbi.nlm.nih.gov/39407127
https://doaj.org/article/31bfdde01fcb44feb8485bed198b315c
https://repository.publisso.de/resource/frl:6512630

xCT as a Predictor for Survival in a Population-Based Cohort of Head and Neck Squamous Cell Carcinoma

Authors: Nissi, Linda Tuominen, Sanni Routila, Johannes et al.

Source: Nissi, L, Tuominen, S, Routila, J, Huusko, T, Ketonen, P, Sundvall, M, Leivo, I, Irjala, H, Minn, H, Grönroos, T J & Ventelä, S 2024, 'xCT as a Predictor for Survival in a Population-Based Cohort of Head and Neck Squamous Cell Carcinoma', Cancer Medicine, vol. 13, no. 21, e70371. https://doi.org/10.1002/cam4.70371

Subject Terms: Humans, Female, Male, Middle Aged, Amino Acid Transport System y+/metabolism, Squamous Cell Carcinoma of Head and Neck/mortality, Prognosis, Aged, Retrospective Studies, Head and Neck Neoplasms/mortality, Biomarkers, Tumor/metabolism, Adult, 80 and over, Immunohistochemistry

File Description: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/39487701; info:eu-repo/semantics/altIdentifier/pissn/2045-7634

Availability: https://research.abo.fi/en/publications/16257fcc-80f2-44ed-bd4e-4b8c054e4545
https://doi.org/10.1002/cam4.70371
https://research.abo.fi/ws/files/65677242/Cancer_Medicine_-_2024_-_Nissi_-_xCT_as_a_Predictor_for_Survival_in_a_Population_Based_Cohort_of_Head_and_Neck_Squamous.pdf
https://research.utu.fi/converis/portal/detail/Publication/459241874
https://www.scopus.com/pages/publications/85208203502
https://urn.fi/URN:NBN:fi-fe202501204626

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12

Authors: Hyun Chang Bhumsuk Keam Yun-Gyoo Lee et al.

Contributors: Hyun Chang Bhumsuk Keam Yun-Gyoo Lee et al.

Source: Cancer Res Treat

Subject Terms: Adult, Male, Immune Checkpoint Inhibitors / therapeutic use, Neutrophils, Clinical Decision-Making, Drug Resistance, Squamous Cell Carcinoma of Head and Neck / drug therapy, Immune check point, Head and neck neoplasms, 03 medical and health sciences, 0302 clinical medicine, Sum of target lesions, 80 and over, Humans, Lymphocyte Count, Lymphocytes, 10. No inequality, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Immune Checkpoint Inhibitors / pharmacology, Squamous Cell Carcinoma of Head and Neck / blood, Head and Neck Neoplasms / mortality, Patient Selection, Local / drug therapy, Platinum refractory, Local / blood, Head and Neck Neoplasms / pathology, Head and Neck Neoplasms / drug therapy, Squamous Cell Carcinoma of Head and Neck / secondary, Middle Aged, Prognosis, Progression-Free Survival, 3. Good health, Neoplasm Recurrence, Drug Resistance, Neoplasm, Head and Neck Neoplasms, Risk Assessment / methods, Neoplasm, Head and Neck Neoplasms / blood, Original Article, Female, Neoplasm Recurrence, Local, Squamous Cell Carcinoma of Head and Neck / mortality, Local / mortality, Biomarkers, Follow-Up Studies

Access URL: http://www.e-crt.org/upload/pdf/crt-2020-824.pdf
https://pubmed.ncbi.nlm.nih.gov/33285051
https://www.ncbi.nlm.nih.gov/pubmed/33285051
http://www.e-crt.org/upload/pdf/crt-2020-824.pdf
https://www.e-crt.org/journal/view.php?number=3184
https://pubmed.ncbi.nlm.nih.gov/33285051/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291197

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis: an individual patient data network meta-analysis

Authors: Z. Takácsi-Nagy B.G. Haffty David M. Brizel et al.

Source: Lancet Oncology, 22, 5, pp. 727-736
Petit, C, Lacas, B, Pignon, J P, Le, Q T, Grégoire, V, Grau, C, Hackshaw, A, Zackrisson, B, Parmar, M K B, Lee, J W, Ghi, M G, Sanguineti, G, Temam, S, Cheugoua-Zanetsie, M, O'Sullivan, B, Posner, M R, Vokes, E E, Cruz Hernandez, J J, Szutkowski, Z, Lartigau, E, Budach, V, Suwiński, R, Poulsen, M, Kumar, S, Ghosh Laskar, S, Mazeron, J J, Jeremic, B, Simes, J, Zhong, L P, Overgaard, J, Fortpied, C, Torres-Saavedra, P, Bourhis, J, Aupérin, A, Blanchard, P, MACH-NC and MARCH Collaborative Groups & Johansen, J 2021, ' Chemotherapy and radiotherapy in locally advanced head and neck cancer : an individual patient data network meta-analysis ', The Lancet Oncology, vol. 22, no. 5, pp. 727-736 . https://doi.org/10.1016/S1470-2045(21)00076-0
Petit, C, Lacas, B, Pignon, J-P, Le, Q T, Grégoire, V, Grau, C, Hackshaw, A, Zackrisson, B, Parmar, M K B, Lee, J-W, Ghi, M G, Sanguineti, G, Temam, S, Cheugoua-Zanetsie, M, O'Sullivan, B, Posner, M R, Vokes, E E, Cruz Hernandez, J J, Szutkowski, Z, Lartigau, E, Budach, V, Suwiński, R, Poulsen, M, Kumar, S, Ghosh Laskar, S, Mazeron, J-J, Jeremic, B, Simes, J, Zhong, L-P, Overgaard, J, Fortpied, C, Torres-Saavedra, P, Bourhis, J, Aupérin, A, Blanchard, P & MACH-NC and MARCH Collaborative Groups 2021, 'Chemotherapy and radiotherapy in locally advanced head and neck cancer : an individual patient data network meta-analysis', The Lancet Oncology, vol. 22, no. 5, pp. 727-736. https://doi.org/10.1016/S1470-2045(21)00076-0

Subject Terms: Male, Radiation, Network Meta-Analysis, Head and Neck Neoplasms/mortality, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Chemoradiotherapy, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Head and Neck Neoplasms, head and neck cancer, radiotherapy, chemotherapy, radiochemotherapy, Humans, Female, Dose Fractionation, Radiation, Medical Oncology - Radboud University Medical Center, Dose Fractionation

File Description: application/pdf

Access URL: https://discovery.ucl.ac.uk/10127198/3/Hackshaw_Manuscript-NetworkMA-MACHNC3-MARCH2%20VF.pdf
https://pubmed.ncbi.nlm.nih.gov/33862002
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/235407
https://doi.org/10.1016/S1470-2045(21)00076-0
https://hdl.handle.net/11370/f2acbe7b-2161-4eec-bff8-00dd313a644b
https://research.rug.nl/en/publications/f2acbe7b-2161-4eec-bff8-00dd313a644b
https://doi.org/10.1016/S1470-2045(21)00076-0
https://discovery.ucl.ac.uk/id/eprint/10127198/
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00076-0/fulltext
https://www.sciencedirect.com/science/article/pii/S1470204521000760
https://europepmc.org/article/MED/33862002
https://scholars.uthscsa.edu/en/publications/chemotherapy-and-radiotherapy-in-locally-advanced-head-and-neck-c
https://www.ncbi.nlm.nih.gov/pubmed/33862002
https://repository.ubn.ru.nl//bitstream/handle/2066/235407/235407.pdf
https://hdl.handle.net/2066/235407
https://portal.findresearcher.sdu.dk/da/publications/07b652a6-74df-4115-941d-2c564cdb10d3
https://doi.org/10.1016/S1470-2045(21)00076-0
https://portal.findresearcher.sdu.dk/da/publications/07b652a6-74df-4115-941d-2c564cdb10d3
https://discovery-pp.ucl.ac.uk/id/eprint/10127198/
https://hdl.handle.net/2318/1844564
https://doi.org/10.1016/S1470-2045(21)00076-0
https://pure.au.dk/portal/en/publications/2bff0ca8-6825-4e22-b9d7-7ed5ba135e9a
http://www.scopus.com/inward/record.url?scp=85105832610&partnerID=8YFLogxK
https://doi.org/10.1016/S1470-2045(21)00076-0

Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data

Authors: Ahmed Bedir Semaw Ferede Abera Ljupcho Efremov et al.

Source: J Cancer Res Clin Oncol

Subject Terms: Adult, Male, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Germany, Humans, Registries, 10. No inequality, Aged, Proportional Hazards Models, Aged, 80 and over, ddc:610, Mediation Analysis, Health Status Disparities, Middle Aged, Survival Analysis, 3. Good health, Socioeconomic Factors, Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Original Article – Cancer Research, Socioeconomic deprivation, Adult [MeSH], Humans [MeSH], Mediation analysis, Survival Analysis [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Mediation Analysis [MeSH], Socioeconomic Factors [MeSH], Head and Neck Neoplasms/mortality [MeSH], Health Status Disparities [MeSH], Survival, Proportional Hazards Models [MeSH], Male [MeSH], Head and neck cancer, Germany [MeSH], Young Adult [MeSH], Registries/statistics, Causality, Head and Neck Neoplasms, Female

File Description: application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007/s00432-021-03537-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33569714
https://link.springer.com/content/pdf/10.1007/s00432-021-03537-2.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021523
https://pubmed.ncbi.nlm.nih.gov/33569714/
https://europepmc.org/article/MED/33569714
https://link.springer.com/article/10.1007/s00432-021-03537-2
https://www.ncbi.nlm.nih.gov/pubmed/33569714
https://repository.publisso.de/resource/frl:6449926

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.

Authors: Couteau, C. Chouaki, N. Leyvraz, S. et al.

Subject Terms: Aged, Antineoplastic Agents, Phytogenic/pharmacokinetics, Phytogenic/therapeutic use, Carcinoma, Squamous Cell/drug therapy, Squamous Cell/mortality, Combined Modality Therapy, Female, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/mortality, Humans, Life Tables, Male, Metabolic Clearance Rate, Middle Aged, Paclitaxel/analogs & derivatives, Paclitaxel/pharmacokinetics, Survival Analysis, Taxoids, Tomography, X-Ray Computed

File Description: application/pdf

Relation: British Journal of Cancer; https://iris.unil.ch/handle/iris/99390; serval:BIB_554804F9BCA7; 000082809800012

Availability: https://iris.unil.ch/handle/iris/99390
https://doi.org/10.1038/sj.bjc.6690715

Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations.

Authors: Lim, A.M. McDowell, L. Hurt, C. et al.

Contributors: Lim, A.M. McDowell, L. Hurt, C. et al.

Subject Terms: Humans, Squamous Cell Carcinoma of Head and Neck/pathology, Squamous Cell Carcinoma of Head and Neck/therapy, Squamous Cell Carcinoma of Head and Neck/mortality, Consensus, Head and Neck Neoplasms/therapy, Head and Neck Neoplasms/pathology, Head and Neck Neoplasms/mortality, Endpoint Determination/standards, Clinical Trials, Phase III as Topic, Progression-Free Survival

Relation: The Lancet Oncology; https://iris.unil.ch/handle/iris/74584; serval:BIB_5888F58ED735

Availability: https://iris.unil.ch/handle/iris/74584
https://doi.org/10.1016/S1470-2045(24)00067-6

End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

Authors: Monnerat, C. Faivre, S. Temam, S. et al.

Subject Terms: Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Biopsy, Needle, Carcinoma, Squamous Cell/drug therapy, Squamous Cell/mortality, Female, Follow-Up Studies, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/mortality, Humans, Male, Neoplasm Metastasis, Neoplasm Staging, Paclitaxel/administration & dosage, Paclitaxel/analogs & derivatives, Randomized Controlled Trials as Topic, Remission Induction, Survival Analysis, Taxoids, Treatment Outcome

Relation: Annals of Oncology; https://iris.unil.ch/handle/iris/71144; serval:BIB_25402; 000177060300012

Availability: https://iris.unil.ch/handle/iris/71144

Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.

Authors: Giralt, J. Tao, Y. Kortmann, R.D. et al.

Subject Terms: Administration, Buccal, Adult, Aged, Analgesics, Opioid/administration & dosage, Chemoradiotherapy/adverse effects, Clonidine/administration & dosage, Clonidine/adverse effects, Confidence Intervals, Deglutition Disorders/etiology, Double-Blind Method, Drug Administration Schedule, Female, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/radiotherapy, Humans, Male, Middle Aged, Placebos/administration & dosage, Radiation-Protective Agents/administration & dosage, Radiation-Protective Agents/adverse effects, Radiotherapy Dosage, Squamous Cell Carcinoma of Head and Neck/radiotherapy, Stomatitis/etiology, Stomatitis/prevention & control, Tablets, Young Adult

Relation: International Journal of Radiation Oncology - Biology - Physics; https://iris.unil.ch/handle/iris/61269; serval:BIB_384C28D80AFF; 000506573200017

Availability: https://iris.unil.ch/handle/iris/61269
https://doi.org/10.1016/j.ijrobp.2019.10.023

Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.

Authors: Leyvraz, S. Pasche, P. Bauer, J. et al.

Subject Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carcinoma, Squamous Cell/drug therapy, Squamous Cell/mortality, Cisplatin/administration & dosage, Cisplatin/adverse effects, Combined Modality Therapy, Drug Administration Schedule, Female, Fluorouracil/administration & dosage, Fluorouracil/adverse effects, Follow-Up Studies, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/mortality, Humans, Leukopenia/etiology, Male, Middle Aged, Radiotherapy/adverse effects, Radiotherapy/methods, Radiotherapy Dosage, Remission Induction, Stomatitis/etiology, Survival Rate, Vindesine/administration & dosage, Vindesine/adverse effects

Relation: Journal of Clinical Oncology; https://iris.unil.ch/handle/iris/242922; serval:BIB_F899ADE6AC3B; A1994PG30000020; 8083711

Availability: https://iris.unil.ch/handle/iris/242922

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations.

Authors: Lim, A.M. Le Tourneau, C. Hurt, C. et al.

Contributors: Lim, A.M. Le Tourneau, C. Hurt, C. et al.

Subject Terms: Humans, Squamous Cell Carcinoma of Head and Neck/pathology, Squamous Cell Carcinoma of Head and Neck/mortality, Squamous Cell Carcinoma of Head and Neck/secondary, Squamous Cell Carcinoma of Head and Neck/therapy, Neoplasm Recurrence, Local/pathology, Consensus, Head and Neck Neoplasms/pathology, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/therapy, Endpoint Determination/standards, Clinical Trials, Phase III as Topic, Neoplasm Metastasis

Relation: The Lancet Oncology; https://iris.unil.ch/handle/iris/215063; serval:BIB_AF66A4CF28EE; 001260855700001

Availability: https://iris.unil.ch/handle/iris/215063
https://doi.org/10.1016/S1470-2045(24)00068-8

Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

Authors: Santa Cruz, O. Tsoutsou, P. Castella, C. et al.

Subject Terms: Adult, Aged, 80 and over, Carcinoma, Squamous Cell/radiotherapy, Chemoradiotherapy/methods, Combined Modality Therapy, Disease-Free Survival, Female, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/radiotherapy, Humans, Male, Middle Aged, Radiotherapy Dosage, Radiotherapy, Conformal/adverse effects, Conformal/methods, Intensity-Modulated/adverse effects, Intensity-Modulated/methods, Retrospective Studies, Survival Rate, Head and neck cancer, Helical tomotherapy, Intensity-modulated RT toxicity

Relation: Oncology; https://iris.unil.ch/handle/iris/212528; serval:BIB_D70AE74A893E; 000440838800001

Availability: https://iris.unil.ch/handle/iris/212528
https://doi.org/10.1159/000489217

Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.

Authors: Tao, Y. Faivre, L. Laprie, A. et al.

Subject Terms: Adult, Aged, Carcinoma, Squamous Cell/mortality, Squamous Cell/therapy, Cetuximab/administration & dosage, Chemoradiotherapy, Female, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/therapy, Humans, Male, Middle Aged, Neoplasm Recurrence, Local/therapy, Re-Irradiation/methods, Salvage Therapy, Squamous Cell Carcinoma of Head and Neck, Cetuximab, Head and neck squamous cell carcinoma, Hyperfractionation, Re-irradiation, Recurrent or second primary

Relation: Radiotherapy & Oncology; https://iris.unil.ch/handle/iris/207370; serval:BIB_820BB085FC44; 000444505600011

Availability: https://iris.unil.ch/handle/iris/207370
https://doi.org/10.1016/j.radonc.2018.05.005

Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.

Authors: Huguenin, P. Beer, K.T. Allal, A. et al.

Subject Terms: Adult, Aged, Carcinoma, Squamous Cell/drug therapy, Squamous Cell/mortality, Cisplatin/therapeutic use, Combined Modality Therapy, Disease-Free Survival, Dose Fractionation, Dose-Response Relationship, Radiation, Female, Follow-Up Studies, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/mortality, Humans, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Invasiveness/pathology, Neoplasm Staging, Probability, Radiotherapy Dosage, Radiotherapy, Adjuvant, Reference Values, Risk Assessment, Statistics, Nonparametric, Survival Analysis

Relation: Journal of Clinical Oncology; https://iris.unil.ch/handle/iris/158393; serval:BIB_77349890A2A0; 000226236600004

Availability: https://iris.unil.ch/handle/iris/158393
https://doi.org/10.1200/JCO.2004.12.193

Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis

Authors: Bosetti, Cristina Bertuccio, Paola Levi, Fabio et al.

Subject Terms: Breast Neoplasms/mortality, Colorectal Neoplasms/mortality, European Union/statistics & numerical data, Female, Head and Neck Neoplasms/mortality, Humans, Male, Mortality/trends, Neoplasms/mortality, Prostatic Neoplasms/mortality, Regression Analysis, Sex Distribution, Sex Factors, Stomach Neoplasms/mortality, Survival Rate, Tobacco Use Cessation/statistics & numerical data, Urinary Bladder Neoplasms/mortality, Uterine Neoplasms/mortality

File Description: application/pdf

Relation: Annals of Oncology; https://iris.unil.ch/handle/iris/149689; serval:BIB_6C44865B656B; 000254470400005

Availability: https://iris.unil.ch/handle/iris/149689
https://doi.org/10.1093/annonc/mdm597

Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy.

Authors: Pehlivan, B. Zouhair, A. Luthi, F. et al.

Subject Terms: Adult, Aged, 80 and over, Blood Loss, Surgical/mortality, Female, Head and Neck Neoplasms/blood, Head and Neck Neoplasms/mortality, Hemoglobins/analysis, Humans, Male, Middle Aged, Neoplasm Staging, Otorhinolaryngologic Surgical Procedures, Postoperative Care, Radiotherapy, Adjuvant/mortality, Survival Analysis, Treatment Outcome

File Description: application/pdf

Relation: Annals of Surgical Oncology; 1534-4681[electronic], 1068-9265[linking]; https://iris.unil.ch/handle/iris/133643; serval:BIB_9F24F250B93C; 000264878900039

Availability: https://iris.unil.ch/handle/iris/133643
https://doi.org/10.1245/s10434-009-0355-2